logo

For the Inventor, By the Inventor

Rome, Italy

Patrizia Minetti

USPTO Granted Patents = 13 


 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 155(Granted Patents)


Location History:

  • Pomezia, IT (2006)
  • Rome, IT (1993 - 2015)

Company Filing History:

goldMedal13 out of 343 
 
Sigma-tau Industrie Farmaceutiche Riunite S.p.a.
 patents

Years Active: 1993-2015

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 9133197 - Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments (2015-09-15),
2. 7713956 - Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity (2010-05-11),
3. RE41226 - Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase (2010-04-12),
4. RE40861 - Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase (2009-07-20),
5. 7098233 - [object Object] (2006-08-29),
6. 7084166 - Bis-heterocyclic compounds with antitumour and chemosensitising activity (2006-08-01),
7. 7078521 - Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo[2,1-b][1,3]benzotiazepines (2006-07-18),
8. 6710041 - Pyrrolo[2,1-B][3,1] benzothiazepines and their use for the preparation of medicaments with antipsychotic activity (2004-03-23),
9. 6444701 - Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase (2002-09-03),
10. 6391870 - Pyrrolo [2,1-b][1,3]benzothiazepines with atypical antipsychotic activity (2002-05-21),
11. 6369073 - Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase (2002-04-09),
12. 5298621 - Oligopeptide derivatives of ipoxantine endowed with immunomodulating (1994-03-29),
13. 5272151 - Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting (1993-12-21),

Title: The Innovative Contributions of Patrizia Minetti

Introduction

Patrizia Minetti is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of medicinal chemistry, holding a total of 13 patents. Her work focuses on developing novel compounds that have therapeutic applications, particularly in treating neurological disorders.

Latest Patents

Among her latest patents is the invention of oxidated derivatives of triazolylpurines, which are useful as ligands of the adenosine A2A receptor. This invention relates to new triazolyl purine derivatives that can be used in pharmaceutical compositions for treating neurological disorders or cerebral ischemia. Another notable patent involves dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines, which exhibit atypical antipsychotic activity. These compounds are particularly useful in the treatment and prevention of schizophrenia and other related disorders.

Career Highlights

Patrizia Minetti is currently associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., where she continues to innovate in the pharmaceutical sector. Her research has led to the development of compounds that not only have therapeutic benefits but also advantageous pharmacokinetic properties.

Collaborations

Throughout her career, Patrizia has collaborated with notable colleagues, including Maria Ornella Tinti and Mauro Marzi. These collaborations have further enhanced her research and contributions to the field.

Conclusion

Patrizia Minetti's work exemplifies the impact of innovative research in the pharmaceutical industry. Her patents reflect a commitment to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…